Abstract. The anti-allergic activity of the 50% methanol extract of Citrus unshiu powder (MEC) was examined. Fifty percent methanol extract of MEC powder showed potent inhibitory activity against histamine release from basophils of patients suffering from seasonal allergic rhinitis to ceder pollen. To examine this anti-allergic mechanism in detail, we next used rat basophlilic leukemia RBL-2H3 cells. MEC significantly inhibited IgE-induced histamine and ß-hexosaminidase release from RBL-2H3 cells. Since MEC contains a variety of flavonoids, we selected nobiletin, hesperetin, and hesperidin (hesperetin glycoside) as representative compounds, and further evaluated these inhibitory activities. Among the flavonoids tested, hesperetin was the most potent, while hesperidin had far less, if any, inhibitory activity. The mechanism by which flavonoids inhibited the degranulation process was then examined. As a result, hesperetin and nobiletin suppressed the phosphorylation of Akt-1, direct downstream effector of phosphatidylinositol 3-kinase (PI3-K). Thus, it was assumed that these flavonoids suppressed IgEmediated stimulation of basophils through PI3-K pathway and that proper intake of Citrus unshiu would be favorable for managing seasonal allergic rhinitis to ceder pollen.
Introduction
Allergic rhinitis is a common allergic disease in industrialized nations, characterized by sneezing, water rhinorrhea, itching in the nose, eyes, and palate, and nasal congestion (1) . Recently, the incidence of both perennial (2) (3) (4) (5) and seasonal allergic rhinitis (6-10) has been increasing worldwide. Seasonal allergic rhinitis (SAR) may occur at any age and affects between 10 and 30% of children (6) . It causes major discomfort in affected patients, such as fatigue, absenteeism, and irritability, adversely affecting the child's adjustment and achievement at school. Therefore, effective management should be directed not only towards rapid and adequate relief of the clinical symptoms but also towards a sustained improvement in the patient's daily life. While conventional therapies for allergic symptoms are advancing steadily, natural products such as phytochemicals and herbal extracts have been widely used by consumers as alternatives to prescription drugs without definitive clinical evidence.
Recently, citrus flavonoids have been reported to possess various pharmacological effects, such as anti-inflammation and even anti-cancer activity (11-13). For these activities, nobiletin, a polymethoxy (5, 6, 7, 8, 3', 4'-hexamethoxy) flavone, is thought to be a responsible compound and has been paid much attention. Concerning the anti-allergic effect of citrus flavonoids, hesperidin is the most famous one. Park et al reported that orally administrated hesperidin, flavanone glycoside, inhibited the passive cutaneous anaphylaxis (PCA) reaction of mice, but exhibited no PCA-inhibitory activity when administered intraperitoneally (14) . Another group also demonstrated that hesperidin did not inhibit histamine release in vitro (15) . However, hesperetin, the flavanone aglycone, inhibited ß-hexosaminidase release in vitro (14) . The antiallergic activities of hesperidin and hesperetin are controversial since the mechanisms by which these citrus flavonoids exert their activities have not been fully clarified yet. In addition, to our knowledge, the anti-allergic activity of nobiletin has not been examined in detail.
For this study, we chose Citrus unshiu, belonging to the family, Rutaceae. It is one of the most popular citrus fruits and its well-known name is Satsuma Mandarin. The ripe fruits are a common food and the dried peels have been used not only in traditional Chinese medicine but also as a skinmoisturizing agent in Japanese folk medicine (16) . Citrus unshiu has been reported to contain several biologically active components, such as auraptene, ß-cryptoxanthin, limonine, hesperidin, nobiletin and tangeretin (11, 17) .
To evaluate the anti-allergic activity of Citrus unshiu, basophils of patients with SAR to Japanese cedar pollen were kindly donated and used in the first part of the present study. We also used the rat basophilic leukemia cell line, RBL-2H3, which has been widely used to examine signal transduction (18) . We show that Citrus unshiu inhibited the chemical mediator release from patients' basophils and from the rat basophilic cell line. We also described the anti-allergic activity of nobiletin and hesperetin and demonstrated that the inhibitory effect was caused, at least in part, by the inhibition of phosphatidylinositol 3-kinase. Histamine release in human basophils. For histamine release assay, leukocyte fractions were prepared by dextran sedimentation (19) using the individual whole blood samples. Histamine release was assayed as described previously (19, 20) . Briefly, basophils from the above mentioned leukocytes were suspended in modified Tyrode buffer (MT, 100 μl) and incubated at 37˚C for a few minutes. Japanese ceder pollen extract (0.1 μg/ml) was added to the leukocytes, and the effects of the addition of MEC (1.6 mg/ml) or wortmannin (positive control, 25 μM) were examined. Wortmannin was dissolved in dimethyl sulfoxide (DMSO) and diluted with MT; the final DMSO concentration was 0.1%. The mixtures were incubated at 37˚C for 40 min and then centrifuged at 400 x g for 5 min. Histamine release in each supernatant was quantified by HPLC according to the on-column conversion method by using o-phthalaldehyde (21) . The results are expressed as the percentage release of histamine amount by pollen extract alone.
Materials and methods

Materials
Inhibitory activity measurement of MEC on RBL-2H3 cells.
The inhibitory activity of MEC and wortmannin against the release of histamine and ß-hexosaminidase from RBL-2H3 cells was evaluated according to the method reported by Watanabe et al (22) . RBL-2H3 cells were purchased from Health Science Research Resource Bank (Japan). Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Carlsbad, CA) containing 10% heat-inactivated fetal calf serum (Invitrogen) was used as a growth medium. The cells were cultured in a 24-well cell culture plate (2.5x10 5 /well, Becton-Dickinson Co., Franklin Lakes, NJ) overnight at 37˚C under a humidified 5% CO 2 atmosphere. The cells were incubated in growth medium containing 50 ng/ml of mouse monoclonal antidinitrophenyl (DNP) IgE for 2 h. After washing with MT, MEC (1.6, 8, or 16 mg/ml) or wortmannin (25 μM) was added. Wortmannin was dissolved in DMSO and diluted with MT; the final DMSO concentration was 0.1%. After 10 min of incubation, DNP-labeled human serum albumin (DNP-labeled HSA, 50 ng/ml final concentration) was added and the culture was incubated for 30 min. The histamine concentration of the resulting supernatant of the cell culture was measured by HPLC using the method described above. The ß-hexosaminidase activity of the supernatant was measured by using the method of Demo et al (23) . Briefly, 50 μl of the supernatant was mixed with 100 μl of a 0.1 M citrate buffer (pH 4.5) containing 3.3 mM p-nitrophenyl-2-acetoamide-ß-D-glucopyranoside and the mixture was incubated in a 96-well plate at 37˚C for 25 min. The reaction was terminated by adding a 2 M glycine buffer (pH 10.4, 100 μl), and absorbance at 405 nm was measured using a microplate reader (model 550, Bio-Rad, CA). The results are expressed as percentage release of histamine or ß-hexosaminidase activity amount by antigen (DNP-labeled HSA) alone.
Inhibitory activity measurement of flavonoids on RBL-2H3 cells and Akt phosphorylation. RBL-2H3 cells were plated at 2.5x10
6 cells per plastic dish (100x20 mm, Corning, NY) in DMEM growth media (10% heat-inactivated FCS) overnight. After washing with MT, flavonoids (100 or 500 μM) or wortmannin (25 μM) were added. Each compound was dissolved in DMSO and diluted with MT. The final DMSO concentration was 0.1%. After 10 min of incubation, DNPlabeled HSA (50 ng/ml final concentration) was added and the culture was incubated for 30 min. The resulting supernatant was collected, and the ß-hexosaminidase activity and histamine concentration were measured using the abovementioned method. Cells were then washed twice with icecold PBS and lysed in 100 μl of NP40 cell lysis buffer (BioSource International, Inc., Camarillo, CA) containing 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich) and 1X protease inhibitor cocktail (Sigma-Aldrich). The reaction was quenched by cooling in an ice bath for 30 min. Lysates were clarified by centrifugation and the total protein concentrations were measured using Protein assay dye reagent (Bio-Rad). Each resulting supernatant was diluted to a final concentration of 200-400 μg/ml. Akt phosphorylation level was investigated by the micro-beads method using Luminex (Hitachi Software, Yokohama, Japan). Briefly, diluted lysates were incubated with Luminex beads conjugated with anti-Akt (total) and anti-phospho-Akt (Ser473) antibody (BioSource International, Inc.) followed by sandwich immunoassay using biotinylated secondary antibodies. Beads were washed three times during each incubation. Phycoerythrin-streptavidin was used as a developing reagent. The relative fluorescence units of Akt (total) and phospho-Akt were detected by counting 100 beads with Luminex apparatus. The data in Fig. 5 are expressed as percentage Akt phosphorylation by antigen (DNP-labeled HSA) alone, based on the calculation of phospho-Akt/Akt (total).
Results
MEC potently inhibited degranulation of basophils.
Firstly, 50% methanol-soluble fraction from the Citrus unshiu powder (MEC) was prepared, and examined for inhibitory effects on histamine release by ceder pollen from four individual basophils of patients with SAR (Fig. 1) . Unfortunately, PBMC from one patient was not reactive to ceder pollen exposure in this assay. For comparison, wortmannin was used as a positive control. MEC as well as wortmannin inhibited the histamine release from basophils of all three patients. The degree of inhibition was patient-dependent; MEC was more potent than wortmannin in patients A and B while wortmannin was more potent in patient C (Fig. 1) .
Practically, the precise examination of degranulation inhibitory activity using basophils of patients is limited. Therefore, the inhibitory activity of MEC on histamine release from sensitized RBL-2H3 cells induced by antigen was examined (Fig. 2) . A test sample is normally added to releasing medium containing cells challenged with the antigen (DNP-labeled HSA). In this case, we assume that the test sample has an effect downstream from the antigen-stimulated stage in the cascade of an immediate type of allergic reaction.
The inhibitory effect of MEC was concentration-dependent. The histamine release at 1.6 mg/ml of MEC was significantly decreased compared to the control (p<0.01), and 16 mg/ml of MEC inhibited histamine release almost perfectly ( Fig. 2A) . Since ß-hexosaminidase was frequently employed as a marker molecule for examining the degranulation process of mast cells (24), we also measured ß-hexosaminidase release from RBL-2H3 to confirm the degranulation inhibitory effect of MEC (Fig. 2B) . The inhibitory effect of MEC was concentrationdependent; the ß-hexosaminidase release at 8 mg/ml of MEC was decreased compared to the control (p<0.01) and reached a plateau at 16 mg/ml of MEC, but no significant inhibitory effect was observed at 1.6 mg of MEC. Judging from both histamine and ß-hexosaminidase release, the inhibitory activity of MEC at around 8 mg/ml seemed to be roughly equal to that of wortmannin at 25 μM. (Fig. 3) . MEC contains a variety of flavonoids, including hesperetin, hesperidin (hesperetin glycoside) and nobiletin, according to HPLC analyses (data not shown). We selected these three flavonoids as representative compounds, and further evaluated their degranulation inhibitory effect. In this study, 500 μM of nobiletin significantly inhibited both histamine (p<0.01) and ß-hexosaminidase (p<0.01) release (Fig. 4) . Hesperetin showed more potent activity; 100 μM of hesperetin significantly inhibited both histamine (p<0.001) and ß-hexosaminidase (p<0.05) release. However, hesperidin (hesperetin glycoside) had no effect on degranulation.
Degranulation inhibitory activity of flavonoids (nobiletin, hesperetin, and hesperidin)
Suppression of PI3-K activity by nobiletin and hesperetin.
The mechanism by which nobiletin and hesperetin inhibited the degranulation process of RBL-2H3 cells was then examined. Since it has been demonstrated that PI3-K is involved in the IgE-mediated stimulation of basophils (25), we examined the involvement of Akt, a serine/threonine kinase and a direct downstream effector of PI3-K (26). Akt phosphorylation was suppressed by wortmannin (25 μM), nobiletin (500 μM) and hesperetin (500 μM) almost equally (Fig. 5) . Unexpectedly, hesperidin (500 μM) also suppressed (but weakly) the phosphorylation. Although phosphorylation of JNK (c-Jun N-terminal stress kinase) and p38 MAPK (mitogen-activated protein kinase) was measured using Luminex-micro-beads at the same time, the obtained data were not explicable (data not shown).
Discussion
Many studies on anti-allergic food compounds have been employed using animal models such as PCA reaction and/or animal cells such as RBL-2H3. The methods using PCA reaction and RBL-2H3 are well-established. In this study, however, basophils of patients with SAR to Japanese cedar pollen were used to demonstrate the anti-allergic activity of Citrus unshiu towards patients directly because it is well known that there are differences in sensitivity to anti-allergic compounds among patients. As shown in Fig. 1 , there were differences in sensitivity to MEC and wortmannin between patients C and A or B. Therefore, MEC might be more effective for patients A and B than C (Fig. 1) . Patient basophil assay would be an excellent tool for predicting the effectiveness of an anti-allergic compound before its administration. On the other hand, since an animal cell line such as RBL-2H3 can be used without limit, it was favorable for the evaluation of the mechanisms by which MEC and flavonoids exert antiallergic effects. We measured the histamine and ß-hexosaminidase release from RBL-2H3 cells, since the enzyme is stored in the secretory granules of mast cells and is released together with such chemical mediators as histamine when mast cells are immunologically activated. As shown in Fig. 4 , the release of ß-hexosaminidase responded more drastically and dosedependently to flavonoid treatment than that of histamine.
According to the data of ß-hexosaminidase (Fig. 4B) , it was found that hesperetin (100 μM) had a most potent degranulation inhibitory activity. Comparing hesperetin (aglycone, Fig. 3 ) and hesperidin (glycoside, Fig. 3) , it was clearly found that only hesperetin had degranulation inhibitory activity in our assay (Fig. 4) . This fact is well correlated with the data of Park et al (14) . According to HPLC analyses, the major flavonoid occurring in Citrus unshiu was hesperidin, while the concentration of hesperetin was low (data not shown). However, hesperidin can be easily metabolized to hesperetin in the intestinal tract (14, 27) . Thus, hesperetin and hesperidin in Citrus unshiu have anti-allergic activity when administered orally (28) . Hesperetin is mainly absorbed as an intact form and is detected in both plasma and urine (14,27), whereas most flavonoids and their glucosides are glucuronidated and metabolized during transfer across the intestine or the liver (29) . Another notable observation was that hesperidin weakly suppressed Akt phosphorylation (Fig. 5) . Further analyses on other signal transduction pathways in which flavone aglycone and glycoside are involved could explain this discrepancy.
Although hesperidin and hesperetin are studied frequently as far as anti-allergic citrus flavonoids are concerned, we conclude that nobiletin should be included. Also, Park et al reported that naringenin exhibited more potent degranulation inhibitory activity than hesperetin (14) . Therefore, comprehensive analyses are necessary to clarify whether other flavonoids (apart from the above-mentioned) in MEC also have this kind of activity.
In conclusion, we have provided direct evidence that Citrus unshiu powder inhibits histamine release from basophils of patients suffering from SAR to ceder pollen. Among the flavonoids in Citrus unshiu powder, hesperetin and nobiletin inhibited the degranulation of RBL-2H3 cells via, at least in part, suppression of PI-3 kinase activity. Therefore, citrus fruit (such as Citrus unshiu) powder would be a useful antiallergic therapy as part of a daily regime, and hesperetin and nobiletin might be therapeutic agents for treating IgE-mediated allergic disorders. A pilot clinical test to apply Citrus unshiu powder to the prevention of SAR is now being planned.
